Stockscreener 앱 받기
92.81
1.19%
-1.295
전일 마감가:
$94.11
열려 있는:
$93.01
하루 거래량:
1.03M
Relative Volume:
0.48
시가총액:
$18.17B
수익:
$8.01B
순이익/손실:
$807.20M
주가수익비율:
22.97
EPS:
4.0411
순현금흐름:
$1.13B
1주 성능:
-6.53%
1개월 성능:
+3.63%
6개월 성능:
-10.46%
1년 성능:
-13.89%
1일 변동 폭
$90.31
$93.22
1주일 범위
$90.31
$98.63
52주 변동 폭
$84.59
$114.44
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
92.88 | 18.41B | 8.01B | 807.20M | 1.13B | 4.0411 |
|
ABT
Abbott Laboratories
|
111.87 | 190.38B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
362.53 | 139.51B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
90.75 | 116.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.68 | 105.88B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.42B | 6.07B | 1.06B | 1.34B | 1.8063 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-20 | 개시 | William Blair | Mkt Perform |
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2026-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Vinva Investment Management Ltd Grows Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Inceptionr LLC Takes Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Dimensional Fund Advisors LP Has $223.50 Million Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Zimmer Biomet Holdings, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
CHF67.50 pre-market 05 Mar 2026: ZBH.SW Zimmer Biomet volume spike signals test - Meyka
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Short Interest Update - MarketBeat
Zimmer Biomet (ZBH) Valuation Check As AAOS 2026 Robotics And Smart Implant Showcase Nears - simplywall.st
Victory Capital Management Inc. Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Growth with a Potential 4.28% Upside - DirectorsTalk Interviews
Mitsubishi UFJ Asset Management Co. Ltd. Buys 22,992 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Citigroup Inc. Reduces Stake in Zimmer Biomet Holdings - National Today
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Citigroup Inc. - MarketBeat
American Century Companies Inc. Sells 532,674 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet’s ROSA Knee v1.5 Pilot Study: What the Latest Update Signals for ZBH Investors - TipRanks
ZBH Should I Buy - Intellectia AI
Pre-market top loser ZBH.SW Zimmer Biomet -4.26% on 27 Feb 2026: support CHF67.50 - Meyka
Primecap Management Co. CA Trims Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
HighTower Advisors LLC Sells 15,738 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet to Release New Data, Highlight Key Innovations at - GuruFocus
How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Debate Growth And Margins - Yahoo Finance
Zimmer Biomet Showcases Robotics And Smart Implants At AAOS 2026 Event - simplywall.st
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting - PR Newswire
Magellan Asset Management Ltd Raises Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) officer granted 10,076 restricted stock units vesting from 2027 - Stock Titan
Zimmer Biomet (NYSE: ZBH) officer granted 9,818 RSUs, with shares withheld for taxes - Stock Titan
[Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity - Stock Titan
ZBH.SW Zimmer Biomet (SIX) at CHF75.00 24 Feb 2026: volume spike tests resistance - Meyka
JPMorgan Chase & Co. Decreases Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to Issue Quarterly Dividend of $0.24 - MarketBeat
Zimmer Biomet (NYSE: ZBH) executive earns 4,843 performance-based RSUs - Stock Titan
ZIMMER BIOMET (ZBH) CEO earns 24,436 performance-based RSUs vesting in 2026 - Stock Titan
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 3.95% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026, Payable on or About April 30, 2026 - marketscreener.com
Zimmer Biomet Keeps Quarterly Dividend at $0.24 a Share, Payable April 30 to Holders of Record as of March 31 - marketscreener.com
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 - Financial Times
Hagens Berman Investigates Zimmer Biomet Over Alleged Emerging Market Failures - National Today
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by AMG National Trust Bank - MarketBeat
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insi - GuruFocus
Zimmer Biomet’s New Stemless Shoulder Study Signals Strategic Push in Joint Reconstruction - The Globe and Mail
Vanguard Group Inc. Acquires 39,929 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $6.12 Million Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
William Blair Initiates Zimmer Biomet Holdings at Market Perform - marketscreener.com
William Blair initiates Zimmer Biomet stock rating at Market Perform - Investing.com
ZIMMER BIOMET HOLDINGS, INC. SEC 10-K Report - TradingView
Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZB - GuruFocus
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.07%
2.02%
자본화:
|
볼륨(24시간):